General Information
Drug ID
DR00856
Drug Name
Mesalazine
Synonyms
2-Hydroxy-5-aminobenzoic acid; 3-carboxy-4-hydroxyaniline; 5 Aminosalicylate; 5 Aminosalicylic Acid; 5-AS; 5-ASA; 5-Amino-2-hydroxybenzoic acid; 5-Aminosalicylate; 5-Aminosalicylic acid; 5-amino-2-hydroxy-benzoic acid; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; AJG-501; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Apriso; Apriso (TN); Asacol; Asacol (TN); Asacol HD; Asacolitin; Asacolon; Asalit; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Canasa; Canasa (TN); Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fisalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Hydrochloride, Mesalamine; Iialda; Iialda (TN); Ipocal (TN); Ipocol; Lialda; Lialda (TN); Lixacol; M Aminosalicylic Acid; M-A; M-Aminosalicylic acid; MAX-002; MD-0901; Masacol (TN); Merckle Brand of Mesalamine; Mesacol; Mesalamine; Mesalamine (USP); Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesalamine [USAN]; Mesalazina; Mesalazina[Spanish]; Mesalazine (JAN/INN); Mesalazine MMX; Mesalazinum; Mesalazinum [Latin]; Mesasal; Mesavance; Mesavancol; Meta Aminosalicylic Acid; Meta-AminosalicylicAcid; Mezavant; Mezavant XL; Minosalicylic acid; Monosodium Salt, Mesalamine; Norgine Brand of Mesalamine; Novo 5 ASA; Novo-5 ASA; Novo5 ASA; Novopharm Brand of Mesalamine; P-Aminosalicylsaeure; P-Aminosalicylsaeure [German]; Pentacol; Pentasa; Pentasa (TN); Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Rowasa; Rowasa (TN); SPD-476; SPD-480; Salicylic acid, 5-amino-(8CI); Salofalk; Salofalk (TN); Salofalk Granu-Stix; Salozinal; Sanofi Synthelabo Brand of Mesalamine; Schering Plough Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SfRowasa; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; Z-206
Drug Type
Small molecular drug
Indication Recurrent ventricular fibrillation [ICD11: BC71.1] Approved [1]
Therapeutic Class
Antiinflammatory Agents
Structure
3D MOL 2D MOL
Formula
C7H6NO3-
Canonical SMILES
C1=CC(=C(C=C1N)C(=O)O)[O-]
InChI
InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)/p-1
InChIKey
KBOPZPXVLCULAV-UHFFFAOYSA-M
CAS Number
CAS 89-57-6
Pharmaceutical Properties Molecular Weight 152.13 Topological Polar Surface Area 86.4
Heavy Atom Count 11 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4
XLogP
2
PubChem CID
54675840
ChEBI ID
ChEBI:6775
TTD Drug ID
D0C4YC
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [3]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OATP1B1 Transporter Info Km = 55.1 microM Human embryonic kidney cells (HEK293)-OATP1B1 [3]
OATP1B3 Transporter Info Km = 77.4 microM Human embryonic kidney cells (HEK293)-OATP1B3 [3]
OATP2B1 Transporter Info Km = 188.9 microM Human embryonic kidney cells (HEK293)-OATP2B1 [3]
References
1 Mesalazine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport studies with 5-aminosalicylate. Eur J Clin Pharmacol. 2006 Oct;62(10):871-5.
3 Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metab Dispos. 2011 Jun;39(6):1097-102.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.